Latest Product Development News

Nexsen has proposed a 50:50 joint venture with FlashDx Shenzhen to develop and commercialise an enhanced molecular Group B Streptococcus test, using an existing CE-marked platform as its starting point. The proposed venture could shorten Nexsen’s path into hospital and intrapartum testing across Asia-Pacific, but the term sheet remains non-binding and regulatory work is still ahead.

Me Today reported a NZ$2.66 million FY26 profit, but the result was dominated by a NZ$4.12 million gain from losing control of King Honey. The remaining business grew revenue and improved its operating loss, yet continued to consume cash and will rely on October warrant funding.

Stakk says recurring contracts now support 100% of its approximately A$55.2 million FY2027 pro-forma revenue forecast, while fresh international wins are being built into the FY2028 growth story. The company will establish Singapore as its non-US commercial, service and technology hub from November 2026.

News Corp has reported record fiscal 2026 revenue of $9 billion, with Total Segment EBITDA exceeding $1.6 billion and free cash flow reaching $811 million. Dow Jones and digital real estate services led the performance, while the company returned $643 million through share buybacks.

Papyrus Australia moved its banana-fibre technology into early commercialisation during FY26, signing an estimated $4.2 million TBS supply contract and delivering commercial-scale samples. But the company ended the year with $257,077 cash, negative equity and an auditor-flagged material uncertainty over its ability to continue as a going concern.

CurveBeam AI has raised A$1.75 million through an oversubscribed SPP shortfall offer and placement, lifting its recent capital raised to A$7.36 million. The funds will support the HiRise China launch, product development, supply-chain preparation and working capital.

Codan Limited (ASX:CDA) has entered FY27 with record revenue, profit and a sharply larger Communications orderbook, while targeting approximately 20% Communications revenue growth. The forecast is conditional on supply-chain capacity as demand for unmanned systems and new gold detectors accelerates.

Dataworks has secured firm commitments for a A$3.0 million placement and will seek up to a further A$1.24 million from shareholders to fund debt repayment, government contract mobilisation and commercial expansion. The raise gives the company more capital to pursue growth, but at a discount that will increase the share count and potentially add substantial option dilution.

Cycliq has secured firm commitments for a $1.5 million placement priced at a steep discount, giving the cycling technology company cash for inventory, AI development and other priorities. The raise also comes with a substantial package of options and further dilution subject to shareholder approval.

Netwealth will acquire AI advice platform Paradino for up to $29 million and invest a further $10 million to scale the business. The deal extends Netwealth beyond platform administration into advice production, while Paradino remains loss-making and separately reported.

InFocus Group Holdings has completed a $465,000 placement, including a $15,000 upsizing, to fund new products and services with a focus on gaming technology. The filing also leaves a discrepancy between the 93 million placement shares announced and the 90 million shares covered by its cleansing notice.

Pacific Edge is positioning Cxbladder for a Medicare-led recovery, but the company remains loss-making with NZ$7.8 million in net cash after a difficult FY26. The investment case now turns on final US coverage, test volumes and whether the enlarged balance sheet can carry the business to scale.